DeepMed Research

Georgetown University

🇬🇹Guatemala

Country: 🇬🇹Guatemala

Ownership: Private

Established: 1789-01-23

Employees: 5K

Market Cap: -

Website: http://www.georgetown.edu

Clinical Trials

Envarsus XR in African American Renal Transplant Recipients

Not Applicable

Terminated

Conditions: Renal Transplant Recipients

Interventions: Drug: ENVARSUS®

First Posted Date: 2016-11-04

Last Posted Date: 2020-03-24

Lead Sponsor: Georgetown University

Target Recruit Count: 18

Registration Number: NCT02956005

Locations: 🇺🇸
Medstar Georgetown Transplant Institute, Washington, District of Columbia, United States

Impact of Nilotinib on Safety, Biomarkers and Clinical Outcomes in Mild to Moderate Alzheimer's Disease

Phase 2

Conditions: Alzheimer's Disease

Interventions: Drug: Placebo Capsule(s) Once a Day by Mouth
Drug: Nilotinib Capsule(s) Once a Day by Mouth

First Posted Date: 2016-10-28

Last Posted Date: 2019-03-13

Lead Sponsor: Georgetown University

Target Recruit Count: 42

Registration Number: NCT02947893

Locations: 🇺🇸
Georgetown University Medical Center, Washington, District of Columbia, United States

Use of Regional Anesthesia in Hip Arthroscopy

Phase 4

Conditions: Hip Injuries

Interventions: Other: Normal Saline Sham Injection
Drug: Ropivacaine
Procedure: General Anesthesia

First Posted Date: 2016-08-02

Last Posted Date: 2018-02-19

Lead Sponsor: Georgetown University

Target Recruit Count: 70

Registration Number: NCT02851888

Locations: 🇺🇸
Georgetown University Medical Center, Washington, District of Columbia, United States

Effectiveness and Efficacy of Dynamic Optimal Timing, a Smart Phone App for Avoiding Pregnancy: an Observational Study

Completed

Conditions: Desire to Avoid Pregnancy

Interventions: Behavioral: Women using Dot to avoid pregnancy

First Posted Date: 2016-07-14

Last Posted Date: 2020-02-17

Lead Sponsor: Georgetown University

Target Recruit Count: 718

Registration Number: NCT02833922

Palbociclib / Letrozole or Fulvestrant in African American Women With HR+ HER2- Breast Cancer

Phase 2

Completed

Conditions: Hormone Receptor Positive HER-2 Negative Breast Cancer

Interventions: Drug: Palbociclib + Letrozole or Fulvestrant

First Posted Date: 2016-02-26

Last Posted Date: 2021-09-28

Lead Sponsor: Georgetown University

Target Recruit Count: 35

Registration Number: NCT02692755

Locations: 🇺🇸
MedStar Washington Hospital Center, Washington, District of Columbia, United States
🇺🇸
MedStar Union Memorial Hospital, Baltimore, Maryland, United States
🇺🇸
MedStar Georgetown University Hospital, Washington, District of Columbia, United States

and more 3 locations

Rehabilitation and Prophylaxis of Anomia in Primary Progressive Aphasia

Not Applicable

Active, not recruiting

Conditions: Anomia
Alzheimer Disease
Aphasia, Primary Progressive

Interventions: Behavioral: Phonological
Behavioral: Semantic
Behavioral: Lexical
Behavioral: Orthographic
Behavioral: Untrained

First Posted Date: 2016-02-05

Last Posted Date: 2023-09-25

Lead Sponsor: Georgetown University

Target Recruit Count: 84

Registration Number: NCT02675270

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
🇺🇸
Georgetown University Medical Center, Washington, District of Columbia, United States

Ph 2 Study of TAS-102 / Bevacizumab Maintenance Therapy Post Induction Chemotherapy in Metastatic Colorectal Cancer

Phase 2

Terminated

Conditions: Metastatic Colorectal Cancer

Interventions: Drug: TAS-102
Drug: Bevacizumab

First Posted Date: 2016-01-13

Last Posted Date: 2018-08-07

Lead Sponsor: Georgetown University

Target Recruit Count: 4

Registration Number: NCT02654639

Locations: 🇺🇸
Georgetown University, Washington, District of Columbia, United States

Outcomes for 2 Operations Versus ≥ 3 Operations in Infected Wounds

Not Applicable

Conditions: Wound Infection

Interventions: Procedure: Debridement

First Posted Date: 2015-09-24

Last Posted Date: 2019-09-12

Lead Sponsor: Georgetown University

Target Recruit Count: 250

Registration Number: NCT02559453

Patient Self Monitoring to Evaluate 30 Day Post Discharge Heart Failure Outcomes

Completed

Conditions: Heart Failure

First Posted Date: 2015-08-19

Last Posted Date: 2017-10-20

Lead Sponsor: Georgetown University

Target Recruit Count: 56

Registration Number: NCT02527759

Locations: 🇺🇸
Medstar, Washington Hospital Center, Washington, D.C., District of Columbia, United States
🇺🇸
Medstar, Georgetown University Hospital, Washington, D.C., District of Columbia, United States

A Crossover Pilot Study of the Effect of Amiloride on Proteinuria

Phase 4

Conditions: Proteinuria

Interventions: Drug: Amiloride
Drug: Triamterene

First Posted Date: 2015-08-13

Last Posted Date: 2020-02-07

Lead Sponsor: Georgetown University

Target Recruit Count: 30

Registration Number: NCT02522650

Locations: 🇺🇸
Georgetown University, Washington, District of Columbia, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy